Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006
Debevec, Lučka, Jerič, Tina, Kovač, Viljem, Bitenc, Marko, Sok, Miha
Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study
Turnsek, Nina, Devjak, Rok, Edelbaher, Natalija, Osrajnik, Ilonka, Unk, Mojca, Vidovic, Dusanka, Jeric, Tina, Janzic, Urska